541 related articles for article (PubMed ID: 11304498)
1. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
[TBL] [Abstract][Full Text] [Related]
2. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
[TBL] [Abstract][Full Text] [Related]
3. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel.
Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL
Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
Wang DW; Yazawa K; George AL; Bennett PB
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
7. Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.
Huang H; Priori SG; Napolitano C; O'Leary ME; Chahine M
Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H288-99. PubMed ID: 21076026
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
[TBL] [Abstract][Full Text] [Related]
9. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.
Vatta M; Ackerman MJ; Ye B; Makielski JC; Ughanze EE; Taylor EW; Tester DJ; Balijepalli RC; Foell JD; Li Z; Kamp TJ; Towbin JA
Circulation; 2006 Nov; 114(20):2104-12. PubMed ID: 17060380
[TBL] [Abstract][Full Text] [Related]
10. Novel gain-of-function mechanism in K(+) channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant.
Lees-Miller JP; Duan Y; Teng GQ; Thorstad K; Duff HJ
Circ Res; 2000 Mar; 86(5):507-13. PubMed ID: 10720411
[TBL] [Abstract][Full Text] [Related]
11. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.
Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG
Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
Wang DW; Makita N; Kitabatake A; Balser JR; George AL
Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
[TBL] [Abstract][Full Text] [Related]
13. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
14. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis.
Wehrens XH; Abriel H; Cabo C; Benhorin J; Kass RS
Circulation; 2000 Aug; 102(5):584-90. PubMed ID: 10920073
[TBL] [Abstract][Full Text] [Related]
15. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
[TBL] [Abstract][Full Text] [Related]
16. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits.
An RH; Wang XL; Kerem B; Benhorin J; Medina A; Goldmit M; Kass RS
Circ Res; 1998 Jul; 83(2):141-6. PubMed ID: 9686753
[TBL] [Abstract][Full Text] [Related]
17. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
Clancy CE; Tateyama M; Kass RS
J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
[TBL] [Abstract][Full Text] [Related]
18. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
[TBL] [Abstract][Full Text] [Related]
19. A missense mutation in the sodium channel β1b subunit reveals SCN1B as a susceptibility gene underlying long QT syndrome.
Riuró H; Campuzano O; Arbelo E; Iglesias A; Batlle M; Pérez-Villa F; Brugada J; Pérez GJ; Scornik FS; Brugada R
Heart Rhythm; 2014 Jul; 11(7):1202-9. PubMed ID: 24662403
[TBL] [Abstract][Full Text] [Related]
20. De novo mutation in the SCN5A gene associated with early onset of sudden infant death.
Wedekind H; Smits JP; Schulze-Bahr E; Arnold R; Veldkamp MW; Bajanowski T; Borggrefe M; Brinkmann B; Warnecke I; Funke H; Bhuiyan ZA; Wilde AA; Breithardt G; Haverkamp W
Circulation; 2001 Sep; 104(10):1158-64. PubMed ID: 11535573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
